Physiopathologie et pharmacotoxicologie placentaire humaine

Type: Research unit evaluation report

Evaluation campaign: 2017-2018 (group D) - Published on: 04/06/2018

Institution(s) concerned: Université Paris Descartes , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics

Keywords: Grossesse ; placenta ; prééclampsie ; retard de croissance ; différenciation trophoblaste ; statut redox ; récepteurs nucléaires ; passage transplacentaire ; barrière biologique ; nouveaux nés ; microbiote ; prématurité ; entéropathie ; transplantation microbiote fécal (TMF) ; SVE5